Q&A on the Future of Psychedelic Medicine
To conclude, the speakers can come together for a Q&A panel to address the importance of the next steps in this evolving field. Psychedelics present an opportunity to revolutionize healthcare, tackling mental health and addiction crises. By understanding the basic science, navigating legal hurdles, and embracing broader policy initiatives, we can ensure a productive and safe future for psychedelic medicine in healthcare.We believe this comprehensive approach will provide attendees with a well-rounded understanding of psychedelic medicine's potential and challenges. We look forward to the opportunity to contribute to the PAINWeek Conference and further the dialogue on this transformative field.
Learning Objectives
- Understand the difference between legalization on a state level versus FDA approval.
- Understand how psychedelic therapy is different from other modes of healing.
- Identify the "unknowns" in the landscape of legalization.
Available Credit
- 1.00 AANP
- 1.00 AANP Pharmacology Hours
- 1.00 ACCME (All Other)
- 1.00 ACCME (MD/DO Only)
- 1.00 ACPE Pharmacy
- 1.00 ANCC
- 1.00 APA